ClinicalTrials.gov Identifier: NCT02086188
Pilot Study of Mirabegron and Behavioral Modification Including Pelvic Floor Exercise for Overactive Bladder in Multiple Sclerosis
Description
Investigator: Ted Brown, MD
For More Information: Shalom Kilcup - 425.899.5369 SEKilcup@evergreenhealth.com
The purpose of this research trial is to find out if treatment with the drug Mirabegron will improve urinary urgency control better than behavioral changes alone. We will enroll 40 patients with MS who have bladder problems. All participants will receive educational material about managing overactive bladder, including pelvic floor exercises. They will be randomized to receive Mirabegron treatment or a placebo (“sugar pill”).
The duration of the study will be about 12 weeks (1-2 weeks of baseline observation followed by about 10 weeks of on-drug observation). There will be 4 scheduled visits during the 12 weeks of participation.
Who Can Participate? Patients aged 18 and older with overactive bladder complaints and a confirmed diagnosis of Multiple Sclerosis. Must be willing to complete diaries regarding bladder activity.
Description
Investigator: Ted Brown, MD
For More Information: Shalom Kilcup - 425.899.5369 SEKilcup@evergreenhealth.com
The purpose of this research trial is to find out if treatment with the drug Mirabegron will improve urinary urgency control better than behavioral changes alone. We will enroll 40 patients with MS who have bladder problems. All participants will receive educational material about managing overactive bladder, including pelvic floor exercises. They will be randomized to receive Mirabegron treatment or a placebo (“sugar pill”).
The duration of the study will be about 12 weeks (1-2 weeks of baseline observation followed by about 10 weeks of on-drug observation). There will be 4 scheduled visits during the 12 weeks of participation.
Who Can Participate? Patients aged 18 and older with overactive bladder complaints and a confirmed diagnosis of Multiple Sclerosis. Must be willing to complete diaries regarding bladder activity.
No comments:
Post a Comment